scorecardresearch
Wednesday, May 1, 2024
Support Our Journalism
HomeHealthCovaxin stock for those aged above 45 to last only one day,...

Covaxin stock for those aged above 45 to last only one day, says Delhi AAP MLA Atishi

According to the Aam Aadmi Party legislator, 1.18 lakh people in Delhi were vaccinated on 15 May and around 10.5 lakh people have taken both vaccine doses so far.

Follow Us :
Text Size:

New Delhi: Delhi has only one day of Covaxin stock left for those aged above 45, healthcare and frontline workers while Covishield doses for this category can last up to five days, AAP MLA Atishi said on Sunday.

Delhi has so far received 44.94 lakh vaccine doses for this age group, of which 41.68 lakh have been administered, she said.

According to the Aam Aadmi Party (AAP) legislator, 1.18 lakh people in Delhi were vaccinated on May 15 and around 10.5 lakh people have taken both vaccine doses so far.

After Sunday evening, the city will have only one day of Covaxin stock and five days of Covishield doses left for those aged 45 years and above. We appeal to the central government to immediately make more vaccines available for this category, she said.

The capital has received 8.17 lakh doses for the 18-44 age group so far, of which 5.25 lakh have been used till Sunday morning, she said.

Since we have exhausted the Covaxin stock for this category, all such vaccination centres have been shut. We have six days of Covishield stock left, she said.

We appeal to the Centre to provide more doses of Covaxin and Covishield. If Covaxin cannot be arranged, more doses of Covishield should be given to keep the inoculation drive going, she said.


Also read: Covaxin effective against coronavirus variants found in India & UK, Bharat Biotech says


 

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular